Skip to main content

Table 1 Characteristics of the studied population. Characteristics of the cohort at the beginning of the study

From: Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes

Patient no.

Sex

Age (y)

Underlying nephropathy

Comorbidities

Medication

Dry weight (kg)

Dialyser surface area(m2)

Dialysis Duration (h)

    

Ischemic cardio-myopathy

Diabetes mellitus

Beta-blockers

Calcium antagonists

Alpha-blockers

ACE-inhibitors or ARB

   

1

F

64

Nephroangiosclerosis

N

N

Y

Y

N

Y

57.00

1.8

3.0

2

F

56

Nephroangiosclerosis

N

N

Y

Y

N

Y

64.00

1.8

3.5

3

F

88

Nephroangiosclerosis

N

N

Y

N

Y

Y

64.00

1.8

3.0

4

M

59

Focal segmental glomerulosclerosis

N

Y

Y

N

N

Y

80.0

2.2

3.5

5

F

75

Diabetic nephropathy

N

Y

Y

Y

Y

Y

48.50

1.8

3.5

6

M

74

Nephroangiosclerosis

N

N

N

N

N

N

71.00

1.8

4.0

7

M

68

IgA nephropathy

Y

N

N

N

N

Y

94.65

1.8

4.0

8

F

65

Diabetic nephropathy

Y

Y

Y

Y

Y

Y

47.00

1.8

3.5

9

F

66

Nephroangiosclerosis

N

N

N

Y

Y

N

49.00

1.8

3.5

10

M

77

Interstitial Nephritis

N

N

N

Y

N

Y

99.50

1.8

3.5

11

M

72

Nephroangiosclerosis

Y

N

Y

N

N

Y

92.00

1.8

3.0

12

F

48

IgA nephropathy

N

Y

Y

N

N

N

64.50

2.2

3.5

13

M

77

Nephroangiosclerosis

Y

N

Y

Y

N

N

89.40

1.8

3.0

14

M

81

Nephroangiosclerosis

N

N

Y

Y

N

N

79.65

1.8

3.5

15

M

59

Diabetic nephropathy

Y

Y

Y

N

N

Y

99.00

1.8

4.0

16

M

88

Nephroangiosclerosi

N

N

Y

N

N

N

65.15

1.8

4.0

18

M

64

Nephroangiosclerosis

N

Y

Y

Y

Y

N

97.00

1.8

3.5

17

F

74

Diabetic nephropathy

N

Y

N

Y

N

N

80.00

1.8

3.5

19

M

65

Focal segmental glomerulosclerosis

N

N

Y

N

N

N

86.00

2.2

4.0

20

F

75

Diabetic nephropathy

Y

Y

Y

N

N

Y

68.50

1.8

3.0

21

M

81

Nephroangiosclerosis

Y

N

Y

N

N

Y

69.20

1.8

4.0

22

M

72

Diabetic nephropathy

Y

Y

N

N

N

Y

88.00

1.8

4.0

23

M

88

Nephroangiosclerosis

Y

Y

N

Y

N

Y

83.50

1.8

3.0

24

M

71

Nephroangiosclerosis

Y

Y

Y

N

N

Y

74.50

2.2

4.5

25

F

70

Nephroangiosclerosis

N

N

Y

Y

N

Y

48.20

1.8

3.0

  1. M, male; F, female; Y, yes; N, no; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor antagonists